Comparative binding to DR4 and DR5 receptors of TRAIL and BNNTs/PAHE/mPEG‐DSPE/TRAIL nanoparticles
Authors:
- 25 January 2017
- journal article
- research article
- Published by Wiley in Journal of Molecular Recognition
- Vol. 30 (7)
Abstract
TRAIL is a member of the tumor necrosis factor family of cytokines, which induces apoptosis of cancer cells, thanks to its binding to its cognate receptors DR5 and DR4. We have recently demonstrated that nanovectorization of TRAIL with single‐walled carbon nanotubes enhanced TRAIL affinity to DR5. In this paper, 1‐pyrenebutyric acid N‐hydroxysuccinimide ester functionalized boron nitride nanotubes (BNNTs) were used to anchor the TRAIL protein. The resulting BNNT/1‐pyrenebutyric acid N‐hydroxysuccinimide ester nanotubes were mixed with methoxy‐poly(ethylene glycol)‐1,2‐distearoyl‐sn‐glycero‐3‐phosphoethanolamine‐N‐conjugates so as to allow a good dispersion of these nanoparticle TRAIL (NPT) in aqueous solution. The difference of binding between NPT and soluble TRAIL to DR4 and DR5 receptors was then studied by the use of affinity chromatography. DR4 and DR5 receptors were thus immobilized on a chromatographic support, and the binding of the 2 ligands TRAIL and NPT to DR4 and DR5 was studied in the temperature range 30°C to 50°C. Negative enthalpy (ΔH) values indicated that van der Waals interactions and hydrogen bonding are engaged favorably at the ligand‐receptor interface. It was shown that their rank‐ordered affinities were strongly different in the sequence TRAILDR4 < NPTDR4 < TRAILDR5 < NPTDR5, and the highest affinity for NPT to DR4 and DR5 receptors observed at low pHs was due to the less accessibility of the His molecular switch to be protonated when TRAIL was immobilized on BNNTs. Taken together, our results demonstrated that nanovectorization of TRAIL with BNNTs enhanced its binding to both DR4 and DR5 receptors at 37°C. Our novel nanovector could potentially be used for delivering TRAIL to cells for cancer treatment.Keywords
This publication has 37 references indexed in Scilit:
- Boron nitride nanotube reinforced hydroxyapatite composite: Mechanical and tribological performance and in-vitro biocompatibility to osteoblastsJournal of the Mechanical Behavior of Biomedical Materials, 2011
- Investigation of interactions between poly-L-lysine-coated boron nitride nanotubes and C2C12 cells: up-take, cytocompatibility, and differentiationInternational Journal of Nanomedicine, 2010
- Assessing cytotoxicity of boron nitride nanotubes: Interference with the MTT assayBiochemical and Biophysical Research Communications, 2010
- Carbon Nanotube Based Artificial Water Channel Protein: Membrane Perturbation and Water TransportationNano Letters, 2009
- Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture TherapyDiscover Nano, 2008
- Carbon nanotubes as photoacoustic molecular imaging agents in living miceNature Nanotechnology, 2008
- Phonon characteristics and cathodolumininescence of boron nitride nanotubesApplied Physics Letters, 2005
- Nanotube Molecular Transporters: Internalization of Carbon Nanotube−Protein Conjugates into Mammalian CellsJournal of the American Chemical Society, 2004
- A Co-pyrolysis Method to Boron Nitride Nanotubes at Relative Low TemperatureChemistry of Materials, 2003
- Apoptosis by Death FactorCell, 1997